Steven Swift to Tetrahydroisoquinolines
This is a "connection" page, showing publications Steven Swift has written about Tetrahydroisoquinolines.
Connection Strength
0.591
-
Diary and patient-reported outcomes in patients with severe overactive bladder switching from tolterodine extended release 4 mg/day to solifenacin treatment: An open-label, flexible-dosing, multicentre study. Clin Drug Investig. 2009; 29(5):305-16.
Score: 0.329
-
Solifenacin is effective for the treatment of OAB dry patients: a pooled analysis. Eur Urol. 2005 Sep; 48(3):483-7.
Score: 0.261